Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
about
Antidepressants versus placebo for depression in primary careEffectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety reviewDevelopment and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment ProfileTreatment of depressive disorders in primary care--protocol of a multiple treatment systematic review of randomized controlled trialsEfficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysisThe depression treatment cascade in primary care: a public health perspective.A systematic review of complex system interventions designed to increase recovery from depression in primary careClinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: a randomized equivalence trialAdherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand.Are men under-treated and women over-treated with antidepressants? Findings from a cross-sectional survey in SwedenPatterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran.Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain.Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.Positive perception of pharmacogenetic testing for psychotropic medicationsHow have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safetyA review of treating depression in diabetes: emerging findings.Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptylineEfficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysisActivation syndrome caused by paroxetine in a cancer patient.The pharmacological management of depressionAntidepressant prescribing patterns in Korea: results from the clinical research center for depression studyA marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVSociodemographic and clinical factors associated with antidepressant type in a national sample of the home health care elderly.General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.Antidepressants and suicide: what is the balance of benefit and harm.The mechanisms by which antidepressants may reduce coronary heart disease riskDepression in the elderly: new concepts and therapeutic approaches.Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.Depression, antidepressants and suicidality: a critical appraisal.Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) StudyInhibition of Efavirenz Metabolism by Sertraline and Nortriptyline and Their Effect on Efavirenz Plasma Concentrations.International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan.Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?Should treatment for depression be based more on patient preference?Association between depression and abuse by partners of women attending general practice: descriptive, cross sectional surveyAge-related response to redeemed antidepressants measured by completed suicide in older adults: a nationwide cohort study.
P2860
Q24239979-CCE0EFB7-2317-409B-A85F-181CF615A900Q24288917-D8FE7428-186C-4C28-BB8F-A20081DFC748Q24556640-64E97BD9-76AF-46F5-A96C-4814B3685E07Q24623483-CF11931C-EEFC-4E04-9C64-53410E1EADABQ26996682-BABDF5DB-C9C0-43C7-BCF5-6D095506E857Q27022217-19E1254B-1F6D-45A4-BD82-4314AE5ABCFCQ27692061-D7C2A088-4E00-4101-B142-D6311CBF8255Q30477883-D98AB311-AF55-4AE9-BCB2-3EAF558019E4Q33309348-D8F7F147-9664-4547-B8B7-031C6D2703A4Q33667696-24F5CF3E-78C4-493D-8C90-FE6F8ABF13ACQ33747700-E10973F2-7888-4BE6-AD93-8B7DF6EC2D83Q33982992-19176131-3BFC-4DDF-A1D1-ABB30868522FQ34293216-F65E6432-91C1-4AB6-99DB-F39BAFFC0B7BQ34438637-FF554A58-D67C-4ABD-8426-23EA62A1E1E2Q34541288-A859E27F-5B85-4E40-BBFD-5D2F952D8855Q34575698-75CF0A88-F84D-4682-A566-D375128BC893Q34590507-2F6449A6-3971-49C9-8CAF-A511414D945DQ34593362-E2702301-385E-4827-8650-E45CE65EBD70Q34597335-5BC82D3A-68A9-4804-A829-28BD4E7DEE01Q34597852-AB6D9A36-F3A9-490D-BE61-78B887E67E28Q34629445-78183B41-A859-4C70-9ED3-8EEB92623673Q34781545-329588C5-E16B-4F55-BDDF-523B55DE1A3CQ35236630-7E7ECBD9-70F9-499D-8C11-045A18E8855CQ35238344-C280D373-0E82-4C3E-8A80-858B60995EA6Q35526694-B14C8DE0-42B5-43B1-9B63-9A515F099BA5Q35528934-E37AB9BA-A84E-449F-8E2C-DA23A8D7290AQ35583918-66D683F0-DD07-42BD-A5CB-A2EDE38F6E07Q35615293-DE69CC56-BA37-410C-BEBF-955843636F3BQ35731801-63138C8A-6893-47F4-A8B0-FE2A07AE227BQ35907504-E19605FC-4E04-485F-8CB5-2FFA4546476EQ35962033-45F042C1-14C3-46F0-B200-2C01BE3BB6EBQ36028253-4EE063E5-806F-44D5-8DC5-F12661735FC1Q36388015-66F5F1F6-85FB-4C29-B397-01D066CB19C2Q36571936-5F7AB33C-64CE-4DDF-BA50-D3DAFA055936Q36944064-9AC7F073-C822-40B7-80F0-6B2A7A1BF2F7Q37037060-8D6697E5-2B30-4F05-A5D4-5F039B16A5DFQ37154511-DEEF6CC7-88D0-400C-BF7D-7042011B3516Q37232239-6025BE95-9F35-44C7-9538-EA5FD8753E68Q37263643-2193867F-4EE7-428C-BA42-7A41706BB129Q37351305-7F10D30A-45F2-4F9D-BBD3-B1CF6CE40323
P2860
Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Efficacy and tolerability of s ...... atic review and meta-analysis.
@ast
Efficacy and tolerability of s ...... atic review and meta-analysis.
@en
Efficacy and tolerability of s ...... atic review and meta-analysis.
@nl
type
label
Efficacy and tolerability of s ...... atic review and meta-analysis.
@ast
Efficacy and tolerability of s ...... atic review and meta-analysis.
@en
Efficacy and tolerability of s ...... atic review and meta-analysis.
@nl
prefLabel
Efficacy and tolerability of s ...... atic review and meta-analysis.
@ast
Efficacy and tolerability of s ...... atic review and meta-analysis.
@en
Efficacy and tolerability of s ...... atic review and meta-analysis.
@nl
P2093
P2860
P1433
P1476
Efficacy and tolerability of s ...... matic review and meta-analysis
@en
P2093
Brian Williams
Bruce Arroll
Frank Sullivan
Iain Crombie
Simon Hatcher
Simon Ogston
P2860
P356
10.1136/BMJ.326.7397.1014
P407
P577
2003-05-01T00:00:00Z